procainamide has been researched along with Dysmyelopoietic Syndromes in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, YS | 1 |
| Shaw, AY | 1 |
| Wang, SG | 1 |
| Hsu, CC | 1 |
| Teng, IW | 1 |
| Tseng, MJ | 1 |
| Huang, TH | 1 |
| Chen, CS | 1 |
| Leu, YW | 1 |
| Hsiao, SH | 1 |
1 other study available for procainamide and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Identification of novel DNA methylation inhibitors via a two-component reporter gene system.
Topics: Anti-Arrhythmia Agents; Antimetabolites, Antineoplastic; Cell Line, Tumor; DNA Methylation; Drug Scr | 2011 |